24 November 2017
News and Views
Links and Services
This week's issue of the New England Journal of Medicine investigates telaprevir for previously untreated chronic Hepatitis C virus infection.
In phase 2 trials, telaprevir, a hepatitis C virus (HCV) genotype 1 protease inhibitor, in combin
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors